Published originally by Logos Technologies prior to Instem ownership, included here for information purposes
BioTeSys Selects Logos Technologies ALPHADAS® eSource And Pro-Active EDC System To Give Clients Real Time Access To Study Data
Logos Technologies, the leading provider of EDC & CTMS solutions to the early phase clinical trial marketplace is pleased to announce that BioTeSys has chosen their market leading, early phase, e-source data capture system and site automation software suite, ALPHADAS which gives clinical research sites unsurpassed tools to accelerate and streamline their clinical trial operations and service.
“What is particularly exciting about our agreement with BioTeSys is that it is not only another client in Europe, but specifically our first Nutraceutical site. We see the exceptional client service that ALPHADAS can bring – real time data direct from the clinic floor, coupled with the industry leading expertise at BioTeSys as a compelling proposition for Nutraceutical sponsors the world over,” said Mark Cusack, VP of Business Development at Logos Technologies.
Christiane Schon, Head of Clinical Studies at BioTeSys said, “BioTeSys chose ALPHADAS, the pro-active, EDC automation system as it provides us with a user and client friendly, time efficient and transparent approach in the area of nutraceutical clinical studies. The challenges with respect to the substantiation of claims in the field of nutrition requires innovative tools to make the whole process competitive. ALPHADAS allows us to meet the recommended quality criteria and the advantages it brings in terms of flexibility, reliability and transparency provides an excellent return on investment. Moreover, the support and implementation of the system is very well organised and very efficient”.
ALPHADAS is an e-Source, pro-active EDC automation system designed specifically for early phase clinical trials which has achieved great success. It is a market proven solution that offers a depth of functionality other systems cannot provide. In addition, through its modular and flexible structure ALPHADAS can be tailored to fit a client’s individual needs. It is a system that ‘fits all’, it can be installed progressively in modules, meeting both a clients’ immediate requirements but also their longer term goals, it is a solution that can be used by all companies, big and small. The dedicated team behind ALPHADAS are Experts in Early Phase EDC and provide an unrivalled level of service, experience and expertise to its clients. Logos Technologies continues to invest in ALPHADAS, even further increasing its performance and functionality making it the ‘System of Choice’ for early phase EDC.
BioTeSys GmbH was founded in 1999 as a spin-off of the University of Hohenheim and over the years evolved into a universal partner for the food, cosmetic and consumer health care industry.